Flores, author of "The Pecan Sheller," and Vanessa L. Torres, author of “On the Wings of la Noche,” are the 2026 recipients of the Pura Belpré Youth Illustrator Award, Children’s Author Award, and ...

Google parent Alphabet has agreed to buy Intersect Power, a data center and clean energy developer, for $4.75 billion in cash, plus the assumption of the company’s debt. The acquisition, which was ...

Google parent Alphabet said it will acquire Intersect, a data center company, for $4.75 billion in cash and the assumption of debt. Alphabet said the acquisition will help bring more data center and ...

FAMILIES HEARTBROKEN BEYOND WORDS. THE WOMAN WHO HELPED BLOW THE WHISTLE ABOUT ALLEGED ANIMAL ABUSE AT A LOCAL DOG DAYCARE IS TALKING ABOUT HER OWN HORRIFIC EXPERIENCE. WE’RE LEARNING MORE ABOUT THE ...

Alphabet Inc. is set to book another sizable paper gain after SpaceX completes a tender offer that effectively values the closely held company at about $800 billion. SpaceX’s insider share sale was ...

Scarlett Johansson and Colin Jost’s baby name was written in the stars—so they didn’t want worldly opinions. As Scarlett mimed a surprised face, she joked, “What’s happening there? I don’t like it.” ...

Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA) candidate clascoterone—both during their first visits, and their seventh ...

Alphabet's valuation looks high, but the catalysts suggest shares remain undervalued. Google Cloud's AI-driven backlog signals accelerating multi-year revenue growth for GOOGL. TPUs could evolve into ...

At Cosmo, we eat, sleep, and breathe celebrity relationships—which is why, for the first time ever, we are honoring the celeb couples who define for us what it means to be famous and in love. Some ...

Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...

Shares of Cosmo Pharmaceuticals (OTCPK:CMOPF) soared as much as 24% in Zurich—the biggest jump since 2008—after the company said that its experimental male hair loss treatment met key endpoints in two ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...